2 Days
Source:
USA TODAY
Drug may soon be sold OTC
The FDA is pursuing over-the-counter access to low-dose vaginal estrogen for menopausal women, potentially by mid-2027, pending evidence that it can be used safely and effectively without medical supervision. Studies cited in the article indicate the treatment can reduce recurrent urinary tract infections by more than half, and research found women aged 55 and older prescribed it were less likely to be hospitalized with UTIs. Officials and medical groups say wider access and physician education could help prevent severe infections, sepsis and deaths.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)